Novel dihydropyridinone and dihydropyrimidinone compounds and their use
WO2018104762A1
Cationic nanoparticles for enhancing infectious capacity of viruses
WO2017042380A1
Novel 5-amino-2-thioimidazole compounds and their use
US2017210710A1
2-oxo-3,4-dihydropyridine-5-carboxylates and their use
FR3038826A1
AUTONOMOUS GUIDING SYSTEM FOR NEEDLE CARRIER EQUIPMENT
KR20170041662A
Compounds, Pharmaceutical Composition and Their Use in Treating Neurodegenerative Diseases
CA2950357A1
Imidazol- or 1,2,4-triazol-derivatives and their use
WO2015189523A1
Derivatives of 2h-pyrazolo[4,3-c]quinolin-3(5h)-one and use thereof
FR3000064A1
SPIROISOXAZOLINE-LIKE COMPOUNDS WITH POTENTIALIZING ACTIVITY OF AN ANTIBIOTIC COMPOSITION AND PHARMACEUTICAL PRODUCT COMPRISING SUCH COMPOUNDS
US2014309238A1
Fluoralkylcarbonyl-oxadiazoles
FR3000491A1
COMPOUNDS FOR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS
EP2708237A1
Pharmaceutical composition for its use in the preventive treatment of infections caused by an intracellular pathogen, more particularly Toxoplasma gondii
FR2986432A1
28KDA GST PROTEINS FROM SCHISTOSOMES FOR USE IN THE TREATMENT OF AUTOIMMUNE INFLAMMATORY DISEASES GENERATING A TH1 AND / OR TH17 RESPONSE
FR2982262A1
NANOPARTICLE COMPRISING A HEART CHARGED WITH PHOSPHOLIPID AND AN ADSORBED PROTEIN ON SAID HEART-USE FOR THE DELIVERY OF A PROTEIN INTO A CELL
EP2371421A1
Ligands of insulin degrading enzyme and their uses
EP2261211A1
1,4-dihydropyridine derivatives and their uses
FR2939698A1
PROCESS FOR PRODUCING FORMULATION AND USE FOR THE DELIVERY OF POLAR MEDICINAL PRODUCTS
EP1914235A1
Chiral tetra-hydro beta-carboline derivatives and applications thereof as antiparasitic compounds
FR2876702A1
PROCESS FOR THE PREPARATION OF A BACTERIAL MACROMOLECULE, THE MACROMOLECULE OBTAINED THEREBY AND THE USE OF SAID MACROMOLECULE FOR PREVENTING AND TREATING INFLAMMATORY RHUMATISMS
US2006246420A1
In vitro diagnostic test for enterovirus infections
